COVID Vaccine Problems News Articles
Below are key excerpts of revealing news articles on COVID vaccine problems from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
No vaccine provides perfect protection, and so-called breakthrough infections after coronavirus vaccination are rare. Federal health officials have told fully vaccinated people they no longer need to wear masks or maintain social distance because they are protected, nor do they need to be tested or quarantine after an exposure, unless they develop symptoms. Now, the Centers for Disease Control and Prevention has stopped investigating breakthrough infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Earlier this year, the agency was monitoring all cases. Through the end of April, when some 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of breakthrough infections from 46 states and territories, a number that was very likely “a substantial undercount,” according to a C.D.C. report. On May 1, the agency decided to investigate only the most severe breakthrough infection cases, while still collecting voluntary reports on breakthrough cases from state and local health departments. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases, but only in limited populations, such as health care workers and essential workers, older adults, and residents at long-term care facilities. But even relatively mild cases of Covid-19 can lead to persistent long-term health problems, and it will be difficult to know the full scope without tracking mild infections as well.
Note: This is a convenient way to make it look like case numbers are dropping more than they actually are, which makes the vaccines look more effective than they really are. Learn more on how the CDC is manipulating case figures in this article. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus vaccine from reliable major media sources.
All covid-19 vaccines currently in use in the US are available under emergency access only. None of the covid-19 vaccines in use are actually “approved.” Through an emergency access mechanism known as Emergency Use Authorisation (EUA), the products being rolled out still technically remain “investigational.” Factsheets distributed to vaccinees are clear: “There is no FDA approved vaccine to prevent covid-19.” One key difference between EUA and approval (also called “licensure,” and which for vaccines is known as a BLA (Biologics License Application)) was the expected length of follow-up of trial participants. Unlike its clear articulation of two months for an EUA, the FDA has not committed to a clear minimum for approval. Among the six “first in disease” vaccines approved by the FDA since 2006, pre-licensure pivotal trials were a median of 23 months in duration. Duration of protection is not the only question that longer, placebo controlled trials can address. They also address vaccine safety. The BMJ asked Moderna, Pfizer, and Janssen (Johnson and Johnson) what proportion of trial participants were now formally unblinded, and how many originally allocated to placebo have now received a vaccine. Pfizer declined to say, but Moderna announced that “as of April 13, all placebo participants have been offered the Moderna covid-19 vaccine and 98% of those have received the vaccine.” In other words, the trial is unblinded, and the placebo group no longer exists.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The factory that Pfizer Inc. plans to use to boost production of its covid-19 vaccine for the massive U.S. inoculation effort was cited by federal inspectors last year for repeated quality-control violations. Food and Drug Administration inspectors visited the McPherson, Kansas, plant at the end of 2019 into January 2020, according to an inspection report. They found the drug giant released medications for sale after failing to thoroughly review quality issues that arose in routine testing, the report shows. Additionally, the report says inspectors found bacteria and mold in supposedly sterile areas, an issue seen in previous visits to the facility. And the plant failed to properly sample drug products to ensure they didn't have excessive levels of certain toxins, the inspectors wrote. The FDA sent Pfizer a warning letter, the agency's strongest rebuke, concerning the factory in 2017 after the agency detected issues similar to those it found in 2020. The FDA concluded that Pfizer had addressed the violations in June 2018, a month before it returned to the facility and found more problems. The company plans to supply the U.S. with 200 million doses of its two-shot vaccine regimen by the end of May. The FDA halted all inspections of drugmaking facilities at the beginning of the Covid-19 pandemic, though it has since resumed some domestic visits. Pfizer's plant in Kansas is also authorized to make the Covid-19 treatment remdesivir.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and Big Pharma corruption from reliable major media sources.
The new coronavirus variants have raised concerns about whether vaccines will remain effective against this disease. But the vaccines themselves could drive the evolution of more mutants. The virus is always mutating. And if one happens to produce a mutation that makes it less vulnerable to the vaccine, that virus could simply multiply in a vaccinated individual. But even if that happens, that's only one step in the process. If the vaccine keeps virus levels low, even mutated viruses, the infected person won't produce enough to spread to other people. Unfortunately, at the moment, scientists can't answer the most basic questions about this process. How much does the virus actually replicate inside a person who has been vaccinated with either one dose or two? And how effective is that vaccine at limiting infection enough so that the virus levels stay low and prevent the spread to other people? Andrew Read at Penn State University says, whatever the answers may be, vaccine resistance or escape, as it's called, isn't nearly as scary as bacteria becoming resistant to antibiotics. And this evolutionary pressure is present for any vaccine that doesn't completely block infection. Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.
Note: This informative article presents further data that vaccines lead to increased mutation in viruses. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A little more than a third of nursing home workers have been getting COVID-19 vaccines when the shots are first offered, U.S. health officials said Monday. The Centers for Disease Control and Prevention gave a national accounting of a problem that's been reported anecdotally — many nursing home workers are not getting the shots. The CDC looked at more than 11,000 nursing homes and skilled nursing facilities that had at least one vaccination clinic between the middle of December and the middle of January. The researchers found that while 78% of residents got at least one shot, only 37.5% of staff members did. Data previously showed that people who work in nursing homes and long-term care facilities get flu vaccines at lower rates than other health-care workers. Surveys suggest that long-term care workers are skeptical the shots work and don't think viruses spread easily from them to the people they care for. The CDC released a second report Monday that offered a larger national look at who has been getting the vaccine. The CDC study found that of the people who got at least one shot between mid-December and mid-January, 63% were women, and 55% were age 50 or older.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The federal official in charge of a $250 million marketing blitz to build trust in the coronavirus vaccines' safety says the campaign will forego trying to convince so-called "anti-vaxxers." Instead, it will focus on swaying those who are simply unsure about the new coronavirus inoculations. The U.S. Department of Health and Human Services calls the campaign's target group the "movable middle," said Deputy Assistant Secretary Mark Weber, who is overseeing the initiative. Sixty percent of respondents in a national survey conducted in November by the Pew Research Center said they would definitely or probably get vaccinated, while 39% said they "definitely or probably" would not. However, just under half of that group, 18%, said it's possible they could change their minds. That's the group the campaign needs to sway.
Note: If the government has to spend $250 million to “convince” Americans the vaccines are safe, how can they then issue mandates requiring vaccines? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Australia on Friday canceled a roughly $750 million plan for a large order of a locally developed coronavirus vaccine after the inoculation produced false positive test results for H.I.V. in some volunteers participating in a trial study. Of the dozens of coronavirus vaccines being tested worldwide, the Australian one was the first to be abandoned. While its developers said the experimental vaccine had appeared to be safe and effective, the false positives risked undermining trust in the effort to vaccinate the public. The Australian setback showed the missteps that can inevitably occur when scientists, during a pandemic that has killed more than 1.5 million people, rush to condense the usual yearslong process to develop vaccines into a matter of months. The trouble that arose with the Australian vaccine, developed by the University of Queensland and the biotech company CSL, was related to its use of two fragments of a protein found in H.I.V. The protein formed part of a molecular “clamp” that researchers placed on the spikes that surround the coronavirus and allow it to enter healthy cells. The clamp stabilizes the spikes, allowing the immune system to respond more effectively to the vaccine. The use of the H.I.V. protein posed no risk of infecting the volunteers with that virus, the researchers said. But the clamp generated the production of antibodies recognized by H.I.V. tests at higher levels than the scientists had expected. The researchers decided to abandon development of the vaccine.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources. Then explore the excellent, reliable resources provided in our Coronavirus Information Center.
Youtube recently banned a video. In the video, Dr. Michael Yeadon said half or even almost all of the tests for COVID are false positives. Youtube banned the video within hours. Perhaps what irked the Big Tech was Yeadon's assertion that the panic over the second or third wave of coronavirus may be unfounded. Yeadon, who had worked as Chief Science Officer for pharmaceutical giant Pfizer for 16 years, went on to say that "this pandemic is fundamentally over." Yeadon argues, citing principles of epidemiology, that a "second wave" of COVID is entirely manufactured. Citing the experience with other recent virus outbreaks - the SARS virus in 2003, and MERS in 2012 - he says that the idea of subsequent waves itself is wrong. Instead, what appears like subsequent waves is actually a single wave occurring in different geographical regions at different points in time. "It is actually multiple single waves affecting geographically distinct populations at different times as the disease spreads. Analyzed individually, each area followed a typical single event," he says about MERS. He gave another blow to the establishment, saying that lockdown did not actually help curb the virus spread. Yeadon cites the now-famous example of Sweden. Covid-19 doomsday preacher Neil Fergusson had said Sweden would see 40,000 deaths by May and 100,000 in later months as it did not lock up people in grids. Yet, Sweden's coronavirus toll is 6,000 as of now.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
Previous vaccines have taken a decade or more to develop, and more than half of the past 20 years have failed in clinical trials. However, four [COVID-19] vaccine candidates have entered the final phase of clinical trials prior to approval by the Food and Drug Administration. Operation Warp Speed ... organized government agencies and private companies with the goal of developing, manufacturing and distributing hundreds of millions of vaccine doses, with starting doses to be available by early 2021. At the head of the operation is Moncef Slaoui, a Moroccan-born Belgian-American scientist. Operation Warp Speed … has invested in six vaccine candidates (Moderna, Pfizer / BioNTech, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi / GSK) with the hope that at least one ... will prove safe and effective in clinical trials. Four of the six vaccine candidates have already been shown to be safe and effective in the first two test phases, which test whether the vaccinations produce so-called neutralizing antibodies. Serious health problems regularly arise during vaccination attempts. "We know how to distribute vaccines to any location in the US," says Slaoui. "It happens every year for flu and shingles." Tracking systems need to be "incredibly precise" to ensure that patients are each given two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed … has selected medical distributor McKesson and cloud operators Google and Oracle to collect and track vaccine data.
Note: The above article is also available here. Don't miss this excellent article which raises many important questions about this operation. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
The Trump administration has compared Operation Warp Speed's crash program to develop a COVID-19 vaccine to the Manhattan Project. And like the notoriously secretive government project to make the first atomic bomb, the details of Operation Warp Speed's work may take a long time to unravel. One reason is that Operation Warp Speed is issuing billions of dollars' worth of coronavirus vaccine contracts to companies through a nongovernment intermediary, bypassing the regulatory oversight and transparency of traditional federal contracting mechanisms, NPR has learned. Instead of entering into contracts directly with vaccine makers, more than $6 billion in Operation Warp Speed funding has been routed through a defense contract management firm called Advanced Technologies International, Inc. ATI then awarded contracts to companies working on COVID-19 vaccines. As a result, the contracts between the pharmaceutical companies and ATI may not be available through public records requests, and additional documents are exempt from public disclosure for five years. [Robin] Feldman, of UC Hastings, says the administration's comparison of Operation Warp Speed to the Manhattan Project is troubling. "I think that's completely the wrong image," she says. "The right analogy, I think, for Operation Warp Speed is the penicillin effort in World War II. We can do a lot of good together, but we have to make sure pharma companies aren't taking advantage of the crisis."
Note: Read an excellent article showing how most of these contracts are linked to the CIA and DHS and more. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
The Centers for Disease Control and Prevention was created to stop deadly pathogens. But 2020 has been a disaster for the CDC. The agency’s response to the worst public health crisis in a century - the coronavirus pandemic - has been marked by technical blunders and botched messaging. The agency has endured false accusations and interference by Trump administration political appointees. Worst of all, the CDC has experienced a loss of institutional credibility at a time when the nation desperately needs to know whom to trust. The stumbles started early in the pandemic, with the botched rollout of test kits suspected of being contaminated at a CDC lab in late January. But the agency’s most chronic problem has been the inability to speak directly and persuasively to the American public. That’s because it has been muzzled ... by political operatives. White House officials have pressured the CDC to change guidance over the last several months to align the guidelines more closely with the administration’s message that the pandemic is under control, federal health officials have said. Those actions include revised CDC guidance on mask-wearing and the reopening of religious institutions and schools. “Every big public health response has two components: the public health emergency and the political emergency,” said a CDC epidemiologist who spoke on the condition of anonymity out of fear of retaliation. “I never would have expected the level of political interference we’re seeing now. It’s so sad.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
AstraZeneca revealed details of its large coronavirus vaccine trials on Saturday, the third in a wave of rare disclosures by drug companies under pressure to be more transparent about how they are testing products that are the world’s best hope for ending the pandemic. Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. Experts have been particularly concerned about AstraZeneca’s vaccine trials, which began in April in Britain, because of the company’s refusal to provide details about serious neurological illnesses in two participants, both women, who received its experimental vaccine in Britain. Those cases spurred the company to halt its trials twice, the second time earlier this month. The studies have resumed in Britain, Brazil, India and South Africa, but are still on pause in the U.S. About 18,000 people worldwide have received AstraZeneca’s vaccine so far. The company has released few details about the two cases of serious illness in its trial. The first participant received one dose of the vaccine before developing inflammation of the spinal cord, known as transverse myelitis. The condition can cause weakness in the arms and legs, paralysis, pain and bowel and bladder problems. The company said it had not confirmed a diagnosis in the second case, a participant who got sick after the second dose of the vaccine. A person familiar with the situation who spoke with The Times on the condition of anonymity said the participant’s illness had been pinpointed as transverse myelitis.
Note: Why won’t the company let the two who became seriously ill speak to the media? And why initially did they hide the fact that the illnesses were serious? And why are top vaccine executives now dumping their shares of stocks? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma corruption from reliable major media sources.
The Trump administration this month announced that one of its largest pandemic-related contracts would go to a little-known biodefense company named Emergent BioSolutions. The $628 million deal to help manufacture an eventual vaccine cemented Emergent's status as the highest-paid and most important contractor to the HHS office responsible for preparing for public health threats and maintaining the government's stockpile of emergency medical supplies. Emergent has long been the government's sole provider of BioThrax, a vaccine for anthrax poisoning. Emergent's advocacy for biodefense spending over more than a decade was aided by influential allies in Washington and tens of millions of dollars in lobbying campaigns. "It has strategically placed itself to be, let's just say, the company that can't fail," said a former senior government official who worked with Emergent on stockpile operations. The company that would become Emergent began as BioPort Corp., formed in 1998 to buy an aging, state-owned company in Lansing, Mich., that was the only licensed supplier of anthrax vaccine to the Pentagon. The Pentagon ... awarded a $29 million no-bid contract for the anthrax vaccine, BioThrax. Controversy swamped the operation. Hundreds of U.S. troops who received the BioThrax treatment complained of bad reactions, such as headaches and nerve problems. Some troops risked courts-martial by refusing vaccination. Emergent spent nearly $4 million on lobbying last year alone.
Note: To understand the huge influence of lobbying and profits on the development and stockpiling of vaccines, don't miss reading this entire, eye-opening article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and vaccines from reliable major media sources.
One by one, vaccine developers at a White House roundtable convened by President Donald Trump in early March pitched their product as a viable solution to the coronavirus. Stéphane Bancel of Moderna Inc. glanced across the table at the nation's top infectious disease expert, Dr. Anthony Fauci, and said he is "very proud to be working with the US government and to have already sent, in only 42 days from the sequence of the virus, our vaccine to Dr. Fauci's team at the NIH." Bancel went on to say that he needed just "a few months" to start phase two of a three-part clinical trial of the sort that typifies vaccine development. (The entire process often takes more than a decade.) The day after the roundtable, the FDA green-lit Moderna's product for trial, making it the first vaccine candidate to advance to the first phase of a clinical study, in which an as-yet unapproved vaccine is injected into the arms of a small group of 45 human volunteers. The effort received another boost on April 16, when the federal Biomedical Advanced Research and Development Authority (BARDA) awarded Moderna up to $483 million to accelerate the development and manufacturing of the vaccine. The FDA allowed Moderna's RNA vaccine ... to essentially gloss over the animal-testing that typically precede clinical trials in humans. [Moderna's former director of chemistry Dr. Suhaib] Siddiqi said this is cause for alarm. "I would not let that [vaccine] be injected in my body," he said. "I would demand: Where is the toxicity data from the lab?"
Note: Read a New York Times/MSN article titled "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine." For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
Two weeks ago, state Sen. Richard Pan introduced a new bill which would require all children K-12 to be vaccinated against COVID-19 in order to attend school in person after Jan. 1, 2023. Unvaccinated children would be forced into remote learning. Pan said, “We need to make sure schools are safe so that all parents are comfortable sending their children to school.” Every parent wants safe schools. But our children deserve medical care driven by facts, not politics. As physician epidemiologists, we have analyzed the data and found that this mandate is not supported by the scientific evidence — which is why no European countries or other U.S. states have implemented their own. California already has a mandate for children over 12, which will be triggered once the vaccines receive full approval. Pan’s bill would go much further, requiring every child in K-12 to be vaccinated while the shots are still under emergency use authorization. Excluding unvaccinated children from in-person learning would come at an enormous cost, at a time when they should be catching up on critical academic and social experiences. In December, when the Los Angeles Unified School District tried to implement a K-12 COVID-19 vaccine mandate, they found that 30,000 students ages 12 and older hadn’t met the mandate requirements. If we extrapolate those numbers to the entire state, and take into account lower vaccination rates among children ages 5-11, over a million California children could be forced into remote learning.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Here in California, our children continue to navigate the most restrictive policies in the country, in many cases not even allowing them to remove their masks while outdoors at school. There are now calls ... to exchange their cloth masks for thicker, larger and tighter N95/KN95 masks. The World Health Organization does not recommend the routine masking of young children at all, let alone the proposition that tight-fitting respirators should be donned by children for multiple hours a day. Yet we have come to view this as appropriate and necessary in California, despite our high levels of protection from serious COVID-19 illness given widespread vaccine uptake. Our government leaders made an implicit promise that the vaccination of adults and children would be the conduit by which our society would return to pre-pandemic freedoms. Despite a highly successful vaccination campaign in the Bay Area, most COVID-19 restrictions have remained in place for two years and counting. And despite widespread access to vaccines, we continue to prioritize the prevention of COVID-19 transmission, even in the absence of severe illness, above most other health considerations. Last week, we began an online petition asking California officials to immediately shift our public dialogue toward defining a path for removing all remaining COVID-19 restrictions in public schools. Despite the pushback we have received, normalizing our school environment is not a radical concept.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.
The Supreme Court’s ruling last week shutting down the Biden administration’s effort to enlist large employers in its vaccination campaign, experts said, would trigger a new wave of uncertainty about how companies keep workers safe from Covid-19. Now Starbucks, with 9,000 U.S. coffee shops and 200,000 workers, has become one of the first major retailers to backtrack on vaccine plans since the ruling. Starbucks told its employees in a memo on Tuesday that they would no longer be required to be fully vaccinated or submit to weekly coronavirus testing. Just two weeks earlier, the company had detailed the requirement and set a deadline of Feb. 9. The Supreme Court’s decision did not prohibit companies from keeping their vaccine rules in place, and many will continue rolling out stringent Covid-19 safety protocols, especially as Covid case counts remain high. Starbucks’s move to drop its vaccine-or-test deadline highlights how the court’s ruling has put the responsibility for determining vaccination rules squarely on employers. And companies face a patchwork of federal, state and local laws, which range from vaccine mandates that are stricter than the federal government’s to laws blocking companies from requiring workers to wear masks. Retailers and their advocates had been among the most vocal critics of the federal government’s vaccine rule, saying it would have exacerbated their struggles to hire or hold on to workers when millions of unemployed Americans remain on the sidelines of the job market.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A federal judge issued a preliminary injunction on Tuesday to halt the start of President Biden’s national vaccine mandate for health care workers, which had been set to begin next week. The injunction, written by Judge Terry A. Doughty, effectively expanded a separate order issued on Monday by a federal court in Missouri. The earlier one had applied only to 10 states that joined in a lawsuit against the president’s decision to require all health workers in hospitals and nursing homes to receive at least their first shot by Dec. 6 and to be fully vaccinated by Jan. 4. “There is no question that mandating a vaccine to 10.3 million health care workers is something that should be done by Congress, not a government agency,” Judge Doughty ... wrote. He added: “It is not clear that even an act of Congress mandating a vaccine would be constitutional.” The judge ... also wrote that the plaintiffs had an “interest in protecting its citizens from being required to submit to vaccinations” and to prevent the loss of jobs and tax revenue that may result from the mandate. In leading a 14-state lawsuit against the mandate, Attorney General Jeff Landry of Louisiana said the federal mandate would blow holes in state budgets and exacerbate shortages in health care facilities. The Biden administration tied compliance with the vaccine mandate to federal funding, requiring immunizations of millions of workers at hospitals, nursing homes or other health facilities that heavily rely on the Medicare or Medicaid programs.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Arizona's attorney general filed a lawsuit Tuesday that seeks to invalidate President Biden's latest COVID-19 vaccine requirements for federal workers and large companies, becoming the first state to mount a legal challenge to the administration's newest rules. In a 14-page complaint filed with a federal district court in Arizona, Attorney General Mark Brnovich argued Mr. Biden's new vaccine requirements unconstitutionally discriminate against U.S. citizens because undocumented immigrants apprehended by federal law enforcement are not subject to a federal vaccination requirement. The attorney general said [the policies] are an "egregious" violation of the Constitution's Equal Protection Clause. "Unauthorized aliens will not be subject to any vaccination requirements ... while roughly a hundred million U.S. citizens will be subject to unprecedented vaccination requirements," the state told the court. Brnovich ... is asking the court to declare the new vaccination policies unconstitutional and block the Biden administration from imposing COVD-19 vaccine mandates on U.S. citizens or legal residents that differ from those applied to undocumented migrants. Mr. Biden announced last week his new vaccination requirements. In addition to signing executive orders requiring all executive branch federal workers and contractors to be vaccinated, the president also said the Department of Labor would be developing an emergency rule to require all employers with at least 100 employees to mandate their workforce be fully vaccinated.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Germany, France, Spain, Italy, Ireland and the Netherlands have joined the growing list of countries that have suspended the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford over blood clot concerns. The Dutch government said Sunday that the Oxford-AstraZeneca vaccine would not be used until at least March 29, while Ireland said earlier in the day that it had temporarily suspended the shot as a precautionary step. On Monday, the German government also said it was suspending its use, with the vaccine regulator, the Paul Ehrlich Institute, calling for further investigations. The Italian medicines authority made a similar announcement on Monday afternoon and French President Emmanuel Macron also said the vaccine’s use would be paused pending a verdict from the EU’s regulator. Spain Health Minister Carolina Darias said Monday that the country will halt use of the shot for at least two weeks. Portugal and Slovenia also suspended the vaccine. Thailand has also halted its planned deployment of the vaccine. The move to pause its use by Dutch and Irish officials came shortly after Norway’s medicines agency said it had been notified of three health workers being treated in hospital for bleeding, blood clots and a low count of blood platelets after receiving the Oxford-AstraZeneca vaccine. Norway has put its Oxford-AstraZeneca vaccine program on hold.
Note: Many countries have resumed using this vaccine after Europe's medicines regulator concluded it was "safe and effective". For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
